Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Free Radic Biol Med. 2016 Oct 15;101:261–271. doi: 10.1016/j.freeradbiomed.2016.10.009

Table 2.

Downregulated pathways in spinal cord of eNAD affected horses. PBonferroni=Bonferroni adjusted P values for gene ontology enrichment analysis, with the associated pathway identification numbers

Pathway name (ID) # genes in Pathway PBonferroni Selected downregulated transcripts (fold change)
Ionotropic glutamate receptor pathway (P00037) 34 1.99 × 10−5 Glutamate receptor Ionotropic, Kainate 3 (GRIK3, −1.77)#
Glutamate receptor 1 (GRIA1; −1.3)#
Metabotropic glutamate receptor 3 (GRM3; −1.48)
Glutamate receptor, Ionotropic, NMDA1 (GRIN1; −1.81)
Vesicle-associated membrane protein 2 (VAMP2; −1.13)#
Synaptic vesicle trafficking pathway (P05734) 20 0.001 Regulating synaptic membrane exocystosis protein (RIMS1; −1.35)
Synaptotagmin 1 (SYT1; −1.53)
Synapsin-2 (SYN2; −1.48)
Protein UNC-13 Homolog C (UNC13C; −1.56)
Synaptogamin-12 (SYT12; −2.35)
Regulating synaptic membrane exocystosis protein (RIMS2; −1.32)
Synaptotagmin 7 (SYT7; −1.48)
Metabotropic glutamate receptor group III pathway (P0039) 45 0.01 Glutamate receptor Ionotropic, Kainate 3 (GRIK3, −1.77)#
Glutamate receptor 1 (GRIA1; −1.3)#
Metabotropic glutamate receptor 5 (GRM5, −1.67)
Cholesterol biosynthesis (P00014) 9 0.02 Squalene Monooxygenase (SQLE, −1.40)
Hydroxymethylglutaryl-CoA Synthase, cytoplasmic (HMGCS1, −1.48)
Diphosphomevalonate decarboxylase (MVD, −1.22)
#

denotes transcripts that overlap between the two pathways